Sandu Pharmaceuticals Ltd — Updates, 30-05-2025: Company Update

Sandu Pharmaceuticals has applied to BSE for approval to reclassify Akshath Finvest and Properties Private Limited, holding 4,94,182 shares (5.12%), from the Promoter Group to the Public shareholder category. This change reduces the promoter group’s stake and potentially increases public float, which can improve liquidity and attract a broader investor base.